Charlotte's Web Backs Bipartisan Plan for a Responsible Federal Hemp Framework That Protects Consumers and Preserves Access
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Charlotte's Web (OTCQX: CWBHF) backed the bipartisan Hemp Guardrails Act, which would replace federal hemp restrictions with a regulated pathway for cannabinoid products.
Introduced by Senators Tim Sheehy and Amy Klobuchar, the proposal would replace Section 781's 0.4 milligram total-THC-per-container limit, set to take effect December 11, 2026. Charlotte's Web supports the bill as a way to protect consumers while preserving access to full-spectrum hemp products. The proposed framework includes FDA oversight, third-party testing, a 21+ age requirement and child-resistant packaging. It would restrict specified intoxicating cannabinoids, prohibit interstate sales of smokable hemp flower and pre-rolls, and raise the cultivation threshold from 0.3% to 1% total THC by dry weight, including THCA. Covered interstate products would require U.S.-grown hemp and domestic processing through labeling.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.The proposed Hemp Guardrails Act would replace the container limit with a regulated pathway Charlotte's Web supports.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed regulatory pathways would cover qualifying hemp-derived cannabinoid products and dietary supplements under federal food and drug law.
- Minor point. Forward-looking: it has not happened yet and may not happen.The proposed cultivation threshold would rise from 0.3% to 1% total THC, including THCA, by dry weight.
- Minor point. Forward-looking: it has not happened yet and may not happen.The proposal would preserve HHS authority to include qualifying cannabinoid supplements in specified CMS and Medicare Advantage benefits.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed interstate passage protections would cover products complying with the federal framework.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Section 781's 0.4 milligram total-THC-per-container limit is set to take effect December 11, 2026.
- Minor pointThe replacement framework remains proposed legislation, rather than an enacted change to Section 781.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed FDA oversight would require manufacturing standards, third-party testing, facility registration, recalls and transparent labeling with analysis certificates.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed consumer safeguards include a 21+ age requirement, child-resistant packaging, warnings and restrictions on marketing to minors.
- Minor point. Forward-looking: it has not happened yet and may not happen.Proposed restrictions cover Delta-8 THC, Delta-10 THC, HHC and THC-O-acetate, alongside continued exclusion of non-naturally producible synthetic cannabinoids.
3 minor points
- Minor point. Forward-looking: it has not happened yet and may not happen.The proposal would prohibit interstate sales of smokable hemp flower and pre-rolls.
- Minor point. Forward-looking: it has not happened yet and may not happen.Covered interstate products would require U.S.-grown hemp and domestic processing, finishing, packaging and labeling.
- Minor point. Forward-looking: it has not happened yet and may not happen.The proposal would preserve states' authority to enact stricter protections.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company urges Congress to replace Section 781's sweeping hemp restrictions with sound, enforceable standards that protect children, eliminate synthetic and restricted intoxicating products such as delta-8 THC, and preserve access to therapeutic hemp products
Louisville, Colorado--(Newsfile Corp. - November 17, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) today announced its strong support for the Hemp Guardrails Act, with bipartisan legislation introduced today by U.S. Senators Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) that would replace the 0.4 milligram per-container limit in Section 781 of the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 and establish a federal regulatory framework that protects consumers while preserving access to responsibly manufactured hemp products.
Section 781, set to take effect December 11, 2026, imposes a 0.4 milligram total-THC-per-container limit that fails to distinguish naturally occurring, non-intoxicating trace THC in full-spectrum hemp from synthetic and intoxicating THC products. Charlotte's Web has consistently challenged an approach that fails to distinguish non-intoxicating full-spectrum products from synthetic and intoxicating THC products.
"This is the moment to get hemp policy right once and for all," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "We thank Senators Sheehy and Klobuchar for their leadership and for putting forward a responsible path that protects consumers without taking away access. We were here when the category began, and for more than a decade we've worked to show what responsible hemp should look like: investing in research, rigorous testing, quality and safety standards, and transparency at every step. Senators Sheehy and Klobuchar's approach recognizes that protecting consumers and protecting access are not competing goals. They are the same responsibility."
The proposed framework would establish strict federal guardrails, including:
- Replacing Section 781's 0.4 mg-per-container restriction with a regulated federal pathway for hemp-derived cannabinoid products;
- Establishing a 21+ age requirement, child-resistant packaging, appropriate warnings and strong protections against marketing to minors;
- Restricting specified intoxicating cannabinoids, including Delta-8 THC, Delta-10 THC, HHC and THC-O-acetate, and prohibiting interstate sale of smokable hemp flower and pre-rolls;
- Continuing to exclude synthetic cannabinoids that cannot be naturally produced by the hemp plant;
- Establishing FDA oversight and enforcement, including manufacturing standards, third-party testing, facility registration, recalls and transparent labeling with access to certificates of analysis;
- Creating regulatory pathways for qualifying hemp-derived cannabinoid products and dietary supplements under the Federal Food, Drug, and Cosmetic Act;
- Increasing the hemp cultivation threshold from
0.3% to1% total THC, including THCA, on a dry-weight basis, while requiring covered interstate products to use U.S.-grown hemp and domestic processing, finishing, packaging and labeling; - Preserving HHS authority to include qualifying cannabinoid dietary supplements in the CMS Beneficiary Engagement Incentive and as specified Medicare Advantage supplemental benefits; and
- Preserving state authority to enact stricter protections, while protecting interstate passage of products that comply with the federal framework.
Veterans, seniors, and families managing complex health challenges are among those who rely on full-spectrum hemp products as a part of their health routines.
"Consumers should not pay the price for an industry fight over market share," said Morachnick. "Senators Sheehy and Klobuchar's proposal gives Congress a path forward: set the highest standards for safety, quality, and accountability, preserve responsible access, and hold all of us to them. Charlotte's Web is ready."
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and a market leader in hemp extract wellness that includes Charlotte's Web whole-plant full-spectrum CBD (cannabidiol) extracts as well as broad-spectrum CBD and other naturally occurring cannabinoid isolates, terpenes, flavonoids, and other beneficial compounds. Charlotte's Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions. Through its substantially vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency with analytical testing from soil to shelf for quality assurance. Charlotte's Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company's website at www.charlottesweb.com.
Forward-Looking Information
Certain information provided herein constitutes forward-looking statements or information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as "may," "will," "should," "could," "would," "anticipate," "expect," "project," "estimate," "forecast," "plan," "intend," "target," "believe" and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements.
Specifically, this press release contains forward-looking statements relating to, but not limited to: whether the Hemp Guardrails Act or comparable legislation is enacted, and the timing of any enactment, including whether it occurs before December 11, 2026 or as part of government funding legislation; the final scope and terms of any such legislation, including its THC thresholds, restricted cannabinoids, age requirement, domestic sourcing requirements, interstate transport protections and preservation of state and federal agency authority; the timing and content of regulations the Food and Drug Administration and the Department of Health and Human Services may adopt under any such legislation; the scope and effect of the restrictions under Section 781 scheduled to take effect on December 11, 2026; the eligibility of the Company's products under any resulting federal framework; and the Company's expectations regarding the development of a durable federal regulatory framework for hemp-derived products. These statements are based on assumptions the Company believes are reasonable, including that the Hemp Guardrails Act or comparable legislation is enacted on substantially the terms described herein and that the Company's products would qualify under the resulting framework. Risks and uncertainties include, among other things: failure of Congress to enact the Hemp Guardrails Act or any other federal hemp framework before December 11, 2026 or at all, or enactment on terms less favorable than anticipated; amendments to the legislation during the legislative process; delays in, or unfavorable outcomes of, federal rulemaking, including the absence of agency guidance on restricted cannabinoids and container limits; additional or more restrictive state laws; costs of complying with new testing, packaging, labeling and registration requirements; the effect on the Company's sales if the Section 781 restrictions take effect as scheduled; and the risk factors discussed under the heading "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings available at www.sec.gov and www.sedarplus.ca.
Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company's behalf, are expressly qualified in their entirety by these cautionary statements.
For further information:
Media inquiries: cw@ampublicrelations.com
Shareholder inquiries: ir@charlottesweb.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/324588
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What hemp legislation is Charlotte's Web supporting?
Charlotte's Web supports the Hemp Guardrails Act, introduced by Senators Tim Sheehy and Amy Klobuchar. It would replace Section 781's 0.4 milligram total-THC-per-container limit with a federal regulatory framework for hemp-derived cannabinoid products.
When does the hemp restriction opposed by Charlotte's Web take effect?
Section 781's 0.4 milligram total-THC-per-container limit is set to take effect December 11, 2026. The Hemp Guardrails Act proposes replacing that restriction; the replacement framework has not been described as enacted.
Would the hemp bill supported by Charlotte's Web override stricter state protections?
The proposed framework would preserve state authority to enact stricter protections, while protecting interstate passage of products that comply with the federal framework.